Cardiovascular Devices
Barostim revenue, results and funding
Barostim filed revenue of $56.7M for 2025.
Data updated Nov 20, 2026 · Back to the company report
$56.7MRevenue, 2025
−$53.3MNet income, 2025
Results by year
| Year | Revenue | Net income | Total assets | LANG_CR_S_M_TAX_PAID | LANG_CR_S_M_TAX_EXPENSE | LANG_CR_S_M_CAPEX | LANG_CR_S_M_SBC | LANG_CR_S_M_RND | LANG_CR_S_M_OPERATING_INCOME | LANG_CR_S_M_CASH | LANG_CR_S_M_DEBT |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $56.7M | −$53.3M | $104.8M | – | −$18k | $580k | $11.1M | $11.1M | −$51.3M | $75.7M | $49.5M |
| 2024 | $51.3M | −$60M | $133.4M | $0 | $55k | $1.4M | $19.1M | $11.1M | −$59.5M | $105.9M | $49.3M |
| 2023 | $39.3M | −$41.2M | $115.2M | $4k | $147k | $591k | $6.3M | $11.6M | −$43.1M | $90.6M | $29.2M |
| 2022 | $22.5M | −$41.4M | $124.9M | $5k | $109k | $685k | $3.9M | $10M | −$42.5M | $106.2M | $6.7M |
| 2021 | $13M | −$43.1M | $152.5M | $2k | $91k | $1.2M | $1.9M | $7.5M | −$26M | $142.1M | $0 |
| 2020 | $6.1M | −$14.1M | $64.8M | $10k | $85k | $311k | $132k | $6.4M | −$11.5M | $59.1M | $19.3M |
Sources: SEC
How to cite
Barostim, Financials. Alion, Nov 20, 2026. https://alion.io/company/barostim/financials
